PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,385.00
Bid: 1,350.00
Ask: 1,420.00
Change: -15.00 (-1.07%)
Spread: 70.00 (5.185%)
Open: 1,400.00
High: 0.00
Low: 0.00
Prev. Close: 1,400.00
OIG Live PriceLast checked at -
Oryx International Growth is an Investment Trust

To generate consistently high absolute returns whilst maintaining a low level of risk for shareholders by investing in small and mid-size quoted and unquoted companies in the UK and US.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

14 Feb 2014 15:00

RNS Number : 1320A
Oryx International Growth Fund Ld
14 February 2014
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

INTERIM MANAGEMENT STATEMENT

FOR THE QUARTER ENDED 31 DECEMBER 2013

 

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FCA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2013 to 31 December 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Manager's Review

 

During the period under review, the FTSE Small Cap Index returned 5.07% and the FTSE All-Share Index returned 4.77%. Against this, the Company's net asset value rose by 10.05%, 43p per share. The Company has benefited from the recent improvement in market conditions and we are pleased to report that the net asset value per share has reached an all-time high.

 

As reported previously, a number of the companies in the Unquoted portfolio are in the process of corporate activity.

 

Material Transactions

During the quarter ended 31 December 2013, the Company purchased 1,176,744 shares for the purposes of cancellation.

 

Material Events

There were no material events during the quarter ended 31 December 2013.

 

Report and Accounts

On 25 November 2013, the Company released its Half-year Report and Condensed Consolidated Financial Statements for the six months ended 30 September 2013, to Shareholders.

 

Financial Highlights

 

31-Dec-13

30-Sep-13

30-Jun-13

31-Mar-13

31-Dec-12

30-Sep-12

30-Jun-12

NAV

£4.77

£4.32

£3.85

£3.78

£3.48

£3.22

£2.93

US Dollar /

Sterling Exchange Rate

1.6562

1.6194

1.5167

1.5182

1.6254

1.6148

1.5685

 

Twenty Largest Equity Investments at 31 December 2013

 

DETAILS

% NET ASSETS

GLEESON (M.J.) GROUP PLC

13.60

GOALS SOCCER CENTRES PLC

7.86

REDCENTRIC PLC

6.61

QUARTO GROUP INC

6.08

GUINNESS PEAT GROUP PLC

5.48

BIOQUELL PLC

5.17

JOURNEY GROUP PLC

5.02

CELSIS AG

4.45

ACCUMULI PLC

4.40

MECOM GROUP PLC

4.28

ASSETCO PLC

3.84

CATALYST MEDIA GROUP PLC

3.39

CVS GROUP PLC

2.79

SINAV LIMTED

2.59

OMG PLC

2.54

CYPROTEX PLC

2.28

TELECITY GROUP PLC

1.96

WALKER CRIPS GROUP PLC

1.94

TEAM ROCK PREF GBP SHARES

1.49

AUGEAN PLC

1.14

TOTAL

86.91

 

 

The financial information for the quarter ended 31 December 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Securities Services S.C.A., Guernsey Branch

for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUPCPUPCGWC
Date   Source Headline
10th May 20249:26 amRNSNet Asset Value(s)
10th Apr 20244:34 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
8th Mar 20245:18 pmRNSNet Asset Value(s)
1st Mar 20249:48 amRNSDirector/PDMR Shareholding
26th Feb 202410:54 amRNSDirector/PDMR Shareholding
19th Feb 202411:51 amRNSDirector/PDMR Shareholding
13th Feb 20245:10 pmRNSDirector/PDMR Shareholding
7th Feb 202410:50 amRNSNet Asset Value(s)
18th Jan 20243:19 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
9th Jan 20244:17 pmRNSNet Asset Value(s)
5th Jan 20249:21 amRNSDirector/PDMR Shareholding
15th Dec 202310:30 amRNSDirector Declaration
11th Dec 202312:52 pmRNSNet Asset Value(s)
21st Nov 202310:21 amRNSHalf-year Report
16th Nov 20238:59 amRNSProposed Sale of The City Pub Group plc
9th Nov 202310:20 amRNSNet Asset Value(s)
19th Oct 20239:00 amRNSInvestment Update
9th Oct 20232:40 pmRNSNet Asset Value(s)
6th Oct 202312:09 pmRNSUpdate on proposed bids for holdings
7th Sep 20235:02 pmRNSNet Asset Value(s)
24th Aug 202310:50 amRNSResult of Annual General Meeting
10th Aug 202310:44 amRNSNet Asset Value(s)
2nd Aug 20237:00 amRNSHolding(s) in Company
26th Jul 20234:00 pmRNSNotice of AGM
11th Jul 202311:23 amRNSNet Asset Value(s)
6th Jul 20237:00 amRNSAnnual Financial Report
14th Jun 20239:25 amRNSDirector Declaration
8th Jun 20234:11 pmRNSNet Asset Value(s)
8th Jun 20238:59 amRNSDirector Declaration
11th May 20234:46 pmRNSNet Asset Value(s)
14th Apr 20239:08 amRNSNet Asset Value(s)
9th Mar 202310:30 amRNSPrevious Shareholding in WANdisco plc
7th Mar 20235:24 pmRNSNet Asset Value(s)
9th Feb 20239:49 amRNSNet Asset Value(s)
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
19th Jan 202310:04 amRNSDirector/PDMR Shareholding
13th Jan 20234:02 pmRNSDirector/PDMR Shareholding
11th Jan 202312:11 pmRNSNet Asset Value(s)
13th Dec 202211:36 amRNSNet Asset Value(s)
9th Dec 20227:00 amRNSHalf-year Report
10th Nov 202210:01 amRNSNet Asset Value(s)
24th Oct 20225:26 pmRNSTR1: Notification of major holdings
12th Oct 20229:30 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTotal Voting Rights
16th Sep 20227:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.